Results 31 to 40 of about 3,671 (174)
Post-finasteride syndrome and post-SSRI sexual dysfunction, are two poorly explored clinical conditions in which men treated for androgenetic alopecia with finasteride or for depression with SSRI antidepressants show persistent side effects despite drug suspension (e.g., sexual dysfunction, psychological complaints, sleep disorders).
Silvia Giatti +3 more
openalex +4 more sources
Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024. [PDF]
BackgroundFinasteride is commonly utilized in clinical practice for treating androgenetic alopecia, but real-world data regarding the long-term safety of its 0adverse events(AEs) remains incomplete, necessitating ongoing supplementation.
Xiaoling Zhong +3 more
doaj +2 more sources
Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study. [PDF]
BackgroundAndrogenetic alopecia (AGA) is extremely prevalent with a multifactorial etiology.MaterialsWe conducted a cross-sectional study using the All of US (AoU) dataset Sept 2024 to better understand the epidemiology, social determinants and ...
Aditya K Gupta +2 more
doaj +2 more sources
MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED? [PDF]
Michael Butcher +9 more
openalex +2 more sources
Post-Finasteride Syndrome: An Underestimated Phenomenon
Ömer Onur Çakır, Ege Can Şerefoğlu
openalex +2 more sources
Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms” [PDF]
Michael A. Perelman
openalex +3 more sources
Pharmacological Management of Pattern Hair Loss
Pattern hair loss (PHL) is a condition that worsens with time and the only way it can be slowed down is with pharmacological intervention. Pharmacological treatments for PHL, from an evidenced-based perspective with respect to safety and efficacy, are ...
Sandeep Suresh Sattur +1 more
doaj +1 more source
Finasteride competitively inhibits 5α-reductase (5-AR) isoenzymes, which blocks dihydrotestosterone (DHT) production, thereby reducing DHT. Finasteride is used in the management of benign prostatic hyperplasia (BPH) and androgenic alopecia.
Haidar Al Saffar +5 more
doaj +1 more source
The treatment with finasteride (i.e., an inhibitor of 5α-reductase) may be associated with different side effects (i.e., depression, anxiety, cognitive impairment and sexual dysfunction) inducing the so-called post finasteride syndrome (PFS).
Silvia Diviccaro +6 more
doaj +1 more source
Male pattern baldness (MPB) has been associated with dihydrotestosterone (DHT) expression. Finasteride treats MPB by inhibiting 5-alpha reductase and blocking DHT production.
Yu Ra Lee +9 more
doaj +1 more source

